MENU
+Compare
ABVX
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$6.16
Change
-$0.07 (-1.12%)
Capitalization
394.15M

ABVX Abivax SA Forecast, Technical & Fundamental Analysis

Industry Biotechnology
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ABVX with price predictions
Jan 08, 2025

ABVX in -8.12% downward trend, sliding for three consecutive days on January 08, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ABVX declined for three days, in of 79 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Aroon Indicator for ABVX entered a downward trend on January 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for ABVX just turned positive on December 31, 2024. Looking at past instances where ABVX's MACD turned positive, the stock continued to rise in of 16 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ABVX advanced for three days, in of 65 cases, the price rose further within the following month. The odds of a continued upward trend are .

ABVX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.933) is normal, around the industry mean (14.744). P/E Ratio (0.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). ABVX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (192.308) is also within normal values, averaging (264.079).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ABVX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABVX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ABVX is expected to report earnings to rise 79.17% to -128 cents per share on March 13

Abivax SA ABVX Stock Earnings Reports
Q4'24
Est.
$-1.29
Q3'24
Beat
by $0.07
Q2'24
Beat
by $0.25
Q4'23
Beat
by $0.08
Q3'23
Est.
$-0.64
The last earnings report on November 07 showed earnings per share of -72 cents, beating the estimate of -79 cents. With 56.92K shares outstanding, the current market capitalization sits at 394.15M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
7-11 boulevard Haussmann
Phone
+33 153830963
Employees
24
Web
https://www.abivax.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGFLX9.800.10
+1.03%
MassMutual Global Adm
NYVTX26.610.26
+0.99%
Davis NY Venture A
GABAX46.530.32
+0.69%
Gabelli Asset AAA
LGOFX28.500.15
+0.53%
Lord Abbett Growth Opportunities F
CNREX23.930.09
+0.38%
Commonwealth Real Estate Securities

ABVX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVX has been loosely correlated with BLUE. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVX jumps, then BLUE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVX
1D Price
Change %
ABVX100%
-1.12%
BLUE - ABVX
33%
Loosely correlated
+1.09%
INZY - ABVX
31%
Poorly correlated
N/A
PLRX - ABVX
30%
Poorly correlated
-3.36%
IDYA - ABVX
30%
Poorly correlated
-2.38%
ADCT - ABVX
30%
Poorly correlated
+4.57%
More